Page last updated: 2024-09-05

orantinib and Cancer of Esophagus

orantinib has been researched along with Cancer of Esophagus in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bruns, CJ; Guba, M; Jauch, KW; Kleespies, A	1
Kitagawa, Y; Kitajima, M; Kubota, T; Nakamura, T; Ozawa, S; Ueda, M	1

Reviews

1 review(s) available for orantinib and Cancer of Esophagus

Article	Year
Vascular endothelial growth factor in esophageal cancer. Journal of surgical oncology, 2004, Aug-01, Volume: 87, Issue:2 Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Barrett Esophagus; Bevacizumab; Carcinoma, Squamous Cell; Esophageal Neoplasms; Humans; Indoles; Lymphangiogenesis; Neovascularization, Pathologic; Oxindoles; Prognosis; Propionates; Protein-Tyrosine Kinases; Pyrroles; RNA, Catalytic; RNA, Messenger; Vascular Endothelial Growth Factor A	2004

Article

Year

Vascular endothelial growth factor in esophageal cancer.

Journal of surgical oncology, 2004, Aug-01, Volume: 87, Issue:2

Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Barrett Esophagus; Bevacizumab; Carcinoma, Squamous Cell; Esophageal Neoplasms; Humans; Indoles; Lymphangiogenesis; Neovascularization, Pathologic; Oxindoles; Prognosis; Propionates; Protein-Tyrosine Kinases; Pyrroles; RNA, Catalytic; RNA, Messenger; Vascular Endothelial Growth Factor A

2004

Other Studies

1 other study(ies) available for orantinib and Cancer of Esophagus

Article	Year
Antiangiogenic agent SU6668 suppresses the tumor growth of xenografted A-431 cells. Oncology reports, 2006, Volume: 15, Issue:1 Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Squamous Cell; Endothelium, Vascular; Esophageal Neoplasms; Humans; Indoles; Mice; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic; Oxindoles; Platelet Endothelial Cell Adhesion Molecule-1; Propionates; Pyrroles; Xenograft Model Antitumor Assays	2006

Article

Year

Antiangiogenic agent SU6668 suppresses the tumor growth of xenografted A-431 cells.

Oncology reports, 2006, Volume: 15, Issue:1

Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Squamous Cell; Endothelium, Vascular; Esophageal Neoplasms; Humans; Indoles; Mice; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic; Oxindoles; Platelet Endothelial Cell Adhesion Molecule-1; Propionates; Pyrroles; Xenograft Model Antitumor Assays

2006